These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10919313)

  • 21. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
    van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
    Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiology of breast carcinoma. Statistical considerations on risk factors].
    Baldi F; Gallo A; Caselli G; Giannantoni C
    Minerva Chir; 1988 Sep; 43(17):1363-6. PubMed ID: 2850511
    [No Abstract]   [Full Text] [Related]  

  • 23. Ductal carcinoma in situ of the breast.
    Burstein HJ; Polyak K; Wong JS; Lester SC; Kaelin CM
    N Engl J Med; 2004 Apr; 350(14):1430-41. PubMed ID: 15070793
    [No Abstract]   [Full Text] [Related]  

  • 24. Selected topics in breast conservation therapy.
    Halverson KJ; Garcia DM; Taylor ME; Perez CA
    Mo Med; 1992 Oct; 89(10):731-9. PubMed ID: 1337137
    [No Abstract]   [Full Text] [Related]  

  • 25. Ductal carcinoma in situ and breast cancer mortality.
    Tanday S
    Lancet Oncol; 2015 Oct; 16(13):e481. PubMed ID: 26321210
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment selection in ductal carcinoma in situ.
    Morrow M; Schnitt SJ
    JAMA; 2000 Jan; 283(4):453-5. PubMed ID: 10659859
    [No Abstract]   [Full Text] [Related]  

  • 27. The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.
    Welch HG; Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2008 Feb; 100(4):228-9. PubMed ID: 18270336
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk of subsequent invasive breast cancer after breast carcinoma in situ.
    Wärnberg F; Yuen J; Holmberg L
    Lancet; 2000 Feb; 355(9205):724-5. PubMed ID: 10703809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
    Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
    Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].
    Krug D; Souchon R
    Strahlenther Onkol; 2016 May; 192(5):349-51. PubMed ID: 27079672
    [No Abstract]   [Full Text] [Related]  

  • 31. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
    Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
    Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable incidence of advanced breast cancer argues against screening effectiveness.
    Autier P; Pizot C; Boniol M
    BMJ; 2014 Nov; 349():g6358. PubMed ID: 25424316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Nolthenius-Puylaert MC; van der Heijden LH; Coebergh JW
    Ned Tijdschr Geneeskd; 2000 Apr; 144(14):659-63. PubMed ID: 10774294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice guideline for the management of ductal carcinoma in-situ of the breast (DCIS).
    American College Of Radiology
    J Am Coll Surg; 2007 Jul; 205(1):145-161. PubMed ID: 17617343
    [No Abstract]   [Full Text] [Related]  

  • 35. Changing pattern of some pathologic parameters of mammary carcinoma.
    Fisher ER; Taylor M
    Cancer; 1973 Dec; 32(6):1380-4. PubMed ID: 4357076
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Barranger E
    Gynecol Obstet Fertil; 2008 Jun; 36(6):704; author reply 704-5. PubMed ID: 18539508
    [No Abstract]   [Full Text] [Related]  

  • 37. Ductal carcinoma in situ: trends in treatment over time in the US.
    Zujewski JA; Harlan LC; Morrell DM; Stevens JL
    Breast Cancer Res Treat; 2011 May; 127(1):251-7. PubMed ID: 20931276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renaming ductal carcinoma in situ: would removing "carcinoma" reduce overtreatment?
    Javid SH; Fang LC; Korde L; Anderson BO
    J Natl Compr Canc Netw; 2014 Apr; 12(4):599-602. PubMed ID: 24717574
    [No Abstract]   [Full Text] [Related]  

  • 40. In situ breast carcinomas: a population-based study on frequency, growth pattern, and clinical aspects.
    Blichert-Toft M; Graversen HP; Andersen J; Dyreborg U; Green A
    World J Surg; 1988 Dec; 12(6):845-51. PubMed ID: 2854930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.